Adjuvant therapy for colon cancer: learning from the past to inform the future.

about

Minichromosome Maintenance Protein 7 is a potential therapeutic target in human cancer and a novel prognostic marker of non-small cell lung cancer

P2860

Q35074445-62CC6457-9169-4DFF-9036-C013DE202858

P2860

Adjuvant therapy for colon cancer: learning from the past to inform the future.

Item

http://www.wikidata.org/entity/Q42868640

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Adjuvant therapy for colon cancer: learning from the past to inform the future.

@en

Adjuvant therapy for colon cancer: learning from the past to inform the future.

@nl

type

Item

label

Adjuvant therapy for colon cancer: learning from the past to inform the future.

@en

Adjuvant therapy for colon cancer: learning from the past to inform the future.

@nl

prefLabel

Adjuvant therapy for colon cancer: learning from the past to inform the future.

@en

Adjuvant therapy for colon cancer: learning from the past to inform the future.

@nl

P1476

Adjuvant therapy for colon cancer: learning from the past to inform the future.

@en

P2093

Axel Grothey

http://www.w3.org/2001/XMLSchema#string

Daniel Sargent

http://www.w3.org/2001/XMLSchema#string

P2860

Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer

End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT Group.

Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials.

Two or three year disease-free survival (DFS) as a primary end-point in stage III adjuvant colon cancer trials with fluoropyrimidines with or without oxaliplatin or irinotecan: data from 12,676 patients from MOSAIC, X-ACT, PETACC-3, C-06, C-07 and C

Long-term survival results of surgery alone versus surgery plus 5-fluorouracil and leucovorin for stage II and stage III colon cancer: pooled analysis of NSABP C-01 through C-05. A baseline from which to compare modern adjuvant trials.

Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.

Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.

A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients.

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation.

P2888

s10434-009-0880-z

P304

947-949

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1245/S10434-009-0880-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41112992

http://www.w3.org/2001/XMLSchema#string

P6179

1052035539

http://www.w3.org/2001/XMLSchema#string

P698

20094919

http://www.w3.org/2001/XMLSchema#string

P932

2840669

http://www.w3.org/2001/XMLSchema#string

Adjuvant therapy for colon cancer: learning from the past to inform the future.

about

P2860

P2860

Adjuvant therapy for colon cancer: learning from the past to inform the future.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698

P932